Clinical characteristics governing treatment adjustment in COPD patients: results from the Swiss COPD cohort study

CONCLUSIONS: This cohort study provides insight into the management of patients with COPD in a primary care setting. COPD Group C and airflow limitation GOLD 3-4 were both associated with an increase in COPD treatment. In patients with comorbidities, there were often no treatment changes. Exacerbations did not make therapy increases more probable. The presence of neither cough/sputum nor high CAT scores was associated with a step up in treatment.PMID:37955986 | DOI:10.57187/smw.2023.40114

Source: Swiss Medical Weekly - November 13, 2023 Category: General Medicine Authors: Lea Kleinsorge Zahra Pasha Maria Boesing Nebal Abu Hussein Pierre O Bridevaux Prashant N Chhajed Thomas Geiser Ladina Joos Zellweger Malcolm Kohler Sabrina Maier David Miedinger Michael Tamm Robert Thurnheer Christophe Von Garnier Joerg D Leuppi Source Type: research